The 2024 Outlook For Global Pharma Calls For More Difficult Days Ahead

The pharma landscape is more volatile than ever before, and pushback on drug prices will continue to intensify from payers, PBMs and especially consumers.

Related Keywords

,National Account Managers ,Numerof Associates ,Pharma Outlook ,Model Report ,Key Account Managers ,Strategic Account ,Commercial Model ,Inflation Reduction Act ,Bringing Value ,Operation Warp Speed ,Pharma Industry ,Drug Pricing ,